Title: Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
Journal: Journal of medicinal chemistry 20141009
Title: ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report.
Journal: American journal of medical genetics. Part A 20140101
Title: Fibrodysplasia ossificans progressiva: clinical and genetic aspects.
Journal: Orphanet journal of rare diseases 20110101
Title: Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
Journal: Human mutation 20090301
Title: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.
Journal: Nature genetics 20060501
